Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. FTLF
FTLF logo

FTLF Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy FitLife Brands Inc (FTLF) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
14.420
1 Day change
0.98%
52 Week Range
20.980
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

FitLife Brands Inc (FTLF) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral to bearish, and the financial performance shows a significant decline in net income and EPS despite revenue growth. Additionally, there are no recent positive news catalysts, trading trends, or influential figure activity to support a buy decision. Given the lack of strong signals and the investor's preference for long-term growth, holding off on this stock is recommended.

Technical Analysis

The MACD is below 0 and negatively contracting, indicating bearish momentum. The RSI is neutral at 57.782, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 14.082 and 14.507, while support levels are at 12.707 and 12.282. Overall, the technical outlook is neutral to bearish.

Positive Catalysts

  • Revenue increased by 46.99% YoY in the latest quarter (2025/Q3).

Neutral/Negative Catalysts

  • Net income dropped by -56.68% YoY, EPS fell by -57.14% YoY, and gross margin declined by -16.16% YoY. No recent news or significant trading trends from hedge funds, insiders, or influential figures. Stock trend analysis suggests minimal short-term upside potential.

Financial Performance

In 2025/Q3, revenue increased to $23,485,000 (up 46.99% YoY), but net income dropped to $921,000 (down -56.68% YoY). EPS fell to 0.09 (down -57.14% YoY), and gross margin decreased to 36.62% (down -16.16% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast FTLF stock price to rise
2 Analyst Rating
Wall Street analysts forecast FTLF stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.280
sliders
Low
21
Averages
23
High
25
Current: 14.280
sliders
Low
21
Averages
23
High
25
Roth Capital
Buy
maintain
$20 -> $25
AI Analysis
2025-08-15
Reason
Roth Capital
Price Target
$20 -> $25
AI Analysis
2025-08-15
maintain
Buy
Reason
Roth Capital raised the firm's price target on FitLife Brands to $25 from $20 and keeps a Buy rating on the shares. The firm is adjusting its estimates to reflect the acquisition, which closed last week, as Irwin Naturals nearly doubles the size of the company and increases its expected adjusted EBITDA by over 50%, with ample opportunity for cost synergies, the analyst tells investors in a research note.

People Also Watch